Sector: MedicalGeron Corporation (NASDAQ: GERN)
Headlines
- Geron Presents Interim Clinical Data on Its Telomerase Inhibitor Drug at AACR-NCI-EORTC
Nov 19, 2009 07:30 AM | GERN
- Geron to Present at LCM Healthcare Conference
Nov 16, 2009 07:30 AM | GERN
- Trading Outlook for StemCells Inc. Issued by InvestorSoup.com
Nov 12, 2009 06:51 AM | GENZ, GERN
- Geron Collaborators Publish Data on hESC-Derived Glial Progenitor Cell Therapy in Cervical Spinal Cord Injury
Nov 11, 2009 07:30 AM | GERN
- Geron and FDA Reach Agreement on Clinical Hold
Oct 30, 2009 12:30 PM | GERN
- Geron Corporation Reports 2009 Third Quarter Financial Results and Events
Oct 29, 2009 04:30 PM | GERN
- Geron Announces Conference Call to Discuss Financial Results for the 2009 Third Quarter
Oct 27, 2009 07:30 AM | GERN
- The Next Big Thing In Health Care: How To Profit From Immunotherapy & Regenerative Medicine
Oct 07, 2009 03:27 PM | BBI, BMRN, BMY, CVM, CYTX, DNA
- StockPreacher.com Issues Trading Outlook for Neuralstem Inc.
Sep 24, 2009 06:52 AM | CRL, GENZ, GERN
- StockPreacher.com Issues Technical Trading Overview for Advanced Cell Technology Inc.
Sep 23, 2009 06:51 AM | ASTM, GERN
- Corning Incorporated and Geron Corporation Showcase New Synthetic Surface Matrices to Enhance Stem Cell Growth
Sep 21, 2009 09:51 AM | GERN, GLW
- SmallCapSentinel.com: Bone Marrow Stem Cell Company Profile Released
Aug 27, 2009 07:01 AM | ASTM, GERN, OSIR
- StockPreacher.com Issues Trading Outlook for Advanced Cell Technology Inc.
Aug 24, 2009 06:51 AM | CYTX, GERN
- Geron Corporation Reports 2009 Second Quarter Financial Results and Events
Jul 30, 2009 04:45 PM | GERN
- Geron Announces Conference Call to Discuss Financial Results for the 2009 Second Quarter
Jul 28, 2009 04:35 PM | GERN
- BenchmarkJournal.Com Free Analyst Review for QLGC, NEXM, GERN, ENDP, LOGI and ALXN
Jul 21, 2009 10:23 AM | ALXN, ENDP, GERN, LOGI, NEXM, QLGC
- InvestorSoup.Com Issues Investment Report for Geron Corp.
Jul 21, 2009 07:57 AM | ASTM, GERN, KOOL
- Geron Scientists and Collaborators Publish Data Showing Functional Dendritic Cells Can Be Derived from Human Embryonic Stem Cells Using Scalable Production Methods
Jul 06, 2009 07:33 AM | GERN
- GE Healthcare and Geron Announce Exclusive Global Agreement to Commercialize Stem Cell Drug Discovery Technologies
Jun 30, 2009 07:31 AM | GE, GERN
- Geron to Present at the 8th Annual Needham Life Sciences Conference
Jun 10, 2009 07:31 AM | GERN
- Form 4 KILEY THOMAS For: May 29 (10K)
Jun 02, 2009 08:17 PM
- Form 4 GERON CORP For: May 29 Filed by: ZENNER PATRICK J (10K)
Jun 01, 2009 11:03 PM
- Form 4 HOMCY CHARLES J For: May 29 (10K)
Jun 01, 2009 11:02 PM
- Form 4 FRITZKY EDWARD V For: May 29 (10K)
Jun 01, 2009 11:01 PM
- Form 4 EASTHAM KARIN For: May 29 (10K)
Jun 01, 2009 11:01 PM
- Form 4 BARKAS ALEXANDER E For: May 29 (10K)
Jun 01, 2009 11:00 PM
- Form 4 Spink Katharine E. For: May 29 (10K)
Jun 01, 2009 10:56 PM
- Form 4 OKARMA THOMAS For: May 29 (10K)
Jun 01, 2009 10:56 PM
- Form 4 LEBKOWSKI JANE For: May 29 (10K)
Jun 01, 2009 10:55 PM
- Form 4 BEHRS MELISSA KELLY For: May 29 (10K)
Jun 01, 2009 10:55 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
GERN
|
Compare to S&P
|
| YTD |
21.20 %
|
0.11 %
|
| 4 Weeks |
-12.92 %
|
-13.39 %
|
| 12 Weeks |
-13.19 %
|
-18.54 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 26.09 %
|
|
EPS Growth in Last Year: 22.73 %
|
|
Sales Growth in Last Quarter: 169.95 %
|
|
Sales Growth in Last Quarter: 34.60 %
|
|
